Super Micro stock rallied late Tuesday after it met a deadline to submit its delayed SEC filings in order to avoid delisting by the Nasdaq.
Sterling (NASDAQ:STRL) Reports Sales Below Analyst Estimates In Q4 Earnings
Civil infrastructure construction company Sterling Infrastructure (NASDAQ:STRL) missed Wall Street’s revenue expectations in Q4 CY2024 as sales rose 2.6% year on year to $498.8 million. On the other hand, the company’s full-year revenue guidance of $2.08 billion at the midpoint came in 0.6% above analysts’ estimates. Its non-GAAP profit of $1.46 per share was 10% above analysts’ consensus estimates.
Workiva (NYSE:WK) Posts Better-Than-Expected Sales In Q4, Stock Soars
Financial and compliance reporting software company Workiva (NYSE:WK) reported Q4 CY2024 results exceeding the market’s revenue expectations, with sales up 19.9% year on year to $199.9 million. The company expects next quarter’s revenue to be around $204 million, close to analysts’ estimates. Its non-GAAP profit of $0.33 per share was in line with analysts’ consensus estimates.
S&P 500 Gains and Losses Today: Stocks Fall for Fourth Day, Led by Weak Sempra Earnings
Major U.S. equities indexes were mixed after a weak consumer confidence report and losses from several noteworthy tech firms.
Lucid (NASDAQ:LCID) Delivers Impressive Q4, Stock Soars
Luxury electric car manufacturer Lucid (NASDAQ:LCID) beat Wall Street’s revenue expectations in Q4 CY2024, with sales up 49.2% year on year to $234.5 million. Its GAAP loss of $0.22 per share was 15.7% above analysts’ consensus estimates.
Masimo (NASDAQ:MASI) Posts Better-Than-Expected Sales In Q4
Medical tech company Masimo (NASDAQ:MASI) reported revenue ahead of Wall Street’s expectations in Q4 CY2024, with sales up 9.4% year on year to $600.7 million. Its non-GAAP profit of $1.80 per share was 26.3% above analysts’ consensus estimates.
Do traders think the stock market looks frothy and overvalued?
Traders are getting concerned about froth in the market, according to a new survey from Schwab.
Merit Medical Systems’s (NASDAQ:MMSI) Q4 Sales Top Estimates
Medical device company Merit Medical Systems (NASDAQ:MMSI) beat Wall Street’s revenue expectations in Q4 CY2024, with sales up 9.4% year on year to $355.2 million. The company expects the full year’s revenue to be around $1.48 billion, close to analysts’ estimates. Its non-GAAP profit of $0.93 per share was 12.2% above analysts’ consensus estimates.
Couchbase’s (NASDAQ:BASE) Q4: Beats On Revenue
Database as a service company Couchbase (NASDAQ: BASE) reported revenue ahead of Wall Street’s expectations in Q4 CY2024, with sales up 9.6% year on year to $54.92 million. On the other hand, next quarter’s revenue guidance of $55.5 million was less impressive, coming in 1.9% below analysts’ estimates. Its non-GAAP loss of $0 per share was significantly above analysts’ consensus estimates.
Olo’s (NYSE:OLO) Q4: Beats On Revenue, Stock Jumps 13.9%
Restaurant software company (NYSE:OLO) reported Q4 CY2024 results topping the market’s revenue expectations, with sales up 20.7% year on year to $76.07 million. Guidance for next quarter’s revenue was better than expected at $77.45 million at the midpoint, 1.4% above analysts’ estimates. Its non-GAAP profit of $0.06 per share was in line with analysts’ consensus estimates.